
Strengthening Health Systems to Reduce Lead Exposure
A partnership between Pure Earth, Vital Strategies, and the Ministries of Health in Colombia, Indonesia, Kyrgyzstan, Maharashtra, India, and Peru to strengthen each country’s national healthcare system to better prevent, identify, and treat lead poisoning.
Today, 1 in 3 children – 800 million – have enough lead in their blood to cause permanent neurological, cognitive, and physical harm.
An estimated 292 million lead-poisoned children live in Colombia, India, Indonesia, Kyrgyzstan, Maharashtra (India), and Peru.
Over the next 5 years, the ministries of health in these 5 countries and states will design and implement new national programs to identify, monitor and reduce lead exposure. By enhancing clinical education and guidelines, strengthening health surveillance technology, and educating teachers and parents on the dangers of lead, countries will be able to better protect children and future generations from lead poisoning.

Stay Up to Date
- Arogya Patrika, Official Publication of the Maharashtra Public Health Department, Highlights Lead Poisoning Prevention Efforts
- Indonesia Kicks Off the First Phase of Blood Lead Surveillance Piloting
- New Video Highlights Government Partnerships and Project Updates During Lead Poisoning Prevention Week
- New Report: Analysis of the capacity of the healthcare system of the Kyrgyz Republic to monitor lead concentrations
- Indonesia: Collaboration + Synergy = The Key
- New Report: Childhood Lead Exposure Prevention: Assessment of Blood Lead Surveillance Capacity in Maharashtra, India

A Global Initiative
Learn more about each project in Colombia, Indonesia, Kyrgyzstan, Peru, and Maharashtra, India.
Funding for this project is provided by Takeda Pharmaceutical Company Limited. Learn more about Takeda’s Global CSR Program.